DD239794A5 - Verfahren zur herstellung von 4-alkoxy-pyrido(2,3-d)-pyrimidin-derivaten - Google Patents

Verfahren zur herstellung von 4-alkoxy-pyrido(2,3-d)-pyrimidin-derivaten Download PDF

Info

Publication number
DD239794A5
DD239794A5 DD85281879A DD28187985A DD239794A5 DD 239794 A5 DD239794 A5 DD 239794A5 DD 85281879 A DD85281879 A DD 85281879A DD 28187985 A DD28187985 A DD 28187985A DD 239794 A5 DD239794 A5 DD 239794A5
Authority
DD
German Democratic Republic
Prior art keywords
pyrido
general formula
alkoxy
pyrimidine derivatives
methyl
Prior art date
Application number
DD85281879A
Other languages
German (de)
English (en)
Inventor
Juergen Kleinschroth
Gerhard Satzinger
Karl Mannhardt
Johannes Hartenstein
Hartmut Osswald
Guenter Weinheimer
Edgar Fritschi
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD239794A5 publication Critical patent/DD239794A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD85281879A 1984-10-19 1985-10-18 Verfahren zur herstellung von 4-alkoxy-pyrido(2,3-d)-pyrimidin-derivaten DD239794A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438351 DE3438351A1 (de) 1984-10-19 1984-10-19 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
DD239794A5 true DD239794A5 (de) 1986-10-08

Family

ID=6248308

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281879A DD239794A5 (de) 1984-10-19 1985-10-18 Verfahren zur herstellung von 4-alkoxy-pyrido(2,3-d)-pyrimidin-derivaten

Country Status (14)

Country Link
US (2) US4681882A (fr)
EP (1) EP0180834B1 (fr)
JP (1) JPS61100582A (fr)
CN (1) CN1004274B (fr)
AT (1) ATE45949T1 (fr)
AU (1) AU579413B2 (fr)
CA (1) CA1257261A (fr)
DD (1) DD239794A5 (fr)
DE (2) DE3438351A1 (fr)
DK (1) DK478585A (fr)
ES (1) ES8605519A1 (fr)
GR (1) GR852529B (fr)
HU (1) HU194227B (fr)
ZA (1) ZA857989B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3501696A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5059602A (en) * 1990-08-27 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
WO2008036682A2 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE525394A (fr) *
US3673184A (en) * 1970-09-02 1972-06-27 Dainippon Pharmaceutical Co Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
US4361700A (en) * 1980-05-20 1982-11-30 James S. Waldron Pyridopyrimidinone derivatives
US4560753A (en) * 1982-11-05 1985-12-24 Sterling Drug Inc. 2-Substituted-pyrido[2,3-d]pyrimidin-5(8H)-ones
US4432981A (en) * 1982-11-05 1984-02-21 Sterling Drug Inc. 2-(Pyridinyl or hydroxyphenyl)-8-substituted pyrido[2,3-d]pyrimidin-5(8H)-ones
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
ATE45949T1 (de) 1989-09-15
CN1004274B (zh) 1989-05-24
CA1257261A (fr) 1989-07-11
GR852529B (fr) 1986-02-19
US4681882A (en) 1987-07-21
DE3572663D1 (en) 1989-10-05
DK478585D0 (da) 1985-10-18
HUT39181A (en) 1986-08-28
JPS61100582A (ja) 1986-05-19
ES548008A0 (es) 1986-03-16
DE3438351A1 (de) 1986-04-24
ES8605519A1 (es) 1986-03-16
HU194227B (en) 1988-01-28
DK478585A (da) 1986-04-20
US4762837A (en) 1988-08-09
ZA857989B (en) 1986-06-25
AU579413B2 (en) 1988-11-24
CN85107614A (zh) 1986-07-16
AU4885685A (en) 1986-04-24
EP0180834A1 (fr) 1986-05-14
EP0180834B1 (fr) 1989-08-30

Similar Documents

Publication Publication Date Title
DE2854115C2 (fr)
EP0528922A1 (fr) Nouveaux composes de sulfonyle
DE3533331A1 (de) Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH639662A5 (de) Imidazoazine und imidazodiazine.
EP0180834B1 (fr) Dérivés de la 4-oxopyrido[2,3-d]pyrimidine, procédé pour leur préparation et médicaments les contenant
EP0133530B1 (fr) Dérivés de 1,6-naphthyridinone, procédé pour leur préparation et médicaments les contenant
EP0665228B1 (fr) Compositions pharmaceutiques contenant 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes
DD253821A5 (de) Verfahren zur herstellung von pyrrolo-benzimidozolen, pyrrolo-benzooxazolen und pyrrolo-benzthiozole
EP0173933B1 (fr) Dérivés de la 1,6-naphthyridine, procédé pour leur préparation et médicaments les contenant
DE3431303C2 (fr)
EP0180833B1 (fr) Dérivés de la 4-oxopyrido[2,3-d]pyrimidine, procédé pour leur préparation et médicaments les contenant
EP0576906A1 (fr) Dérivés et thiénothiazine, procédé pour leur préparation et leur utilisation comme agents anti-inflammatoires et analgésiques.
EP0253171A1 (fr) Pyrido[1,8]naphtyridinones, leur procédé de préparation, leur utilisation et compositions les contenant
EP0301245B1 (fr) Composés de 3-sulfonyl-3,7-diazabicyclo-(3,3,1)nonane, leurs procédés de préparation et médicaments contenant ces composés
CH641800A5 (de) Pyrido-pyrimidine, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittel.
EP0189898A1 (fr) Dérivés de naphtyridine-1,6-one et leur procédé de préparation
EP0189870A1 (fr) Dérivés de la 5-alcoxy-pyrido[4,3-d]pyrimidine, leur procédé de préparation et médicaments les contenant
DE3020895A1 (de) Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
CH653335A5 (de) Verfahren zur herstellung von 9-amino-6,7dihydro-4h-pyrido (1,2-a)pyrimidin-4-on-derivaten.
EP0189883A1 (fr) Dérivés de la 5-oxo[4,3-d]pyrimidine, leur procédé de préparation et médicaments les contenant
DE3602655A1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
DE4216028A1 (de) 2-(Substituierte Imino)-thiazolidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel sowie ihre Verwendung
DE3502790A1 (de) 1,6-naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung
AT325620B (de) Verfahren zur herstellung von neuen triazolothienodiazepinverbindungen und deren säureadditionssalzen
DE3609795A1 (de) Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee